Cellectar Biosciences, Inc.
CLRBNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $14.56M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.15$5.07
- Volume (live)
- -
- Avg. volume (3M)
- 121.61K
Cellectar Biosciences (CLRB) Stock Price & Financial Analysis
Cellectar Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.12 - $1.28 |
|---|---|
| 52-Week High | $5.07 |
| 52-Week Low | $1.15 |
| Open | $1.19 |
| Volume (last close) | 339.00K |
| Average Volume (3M) | 121.61K |
| 50-Day MA | $2.21 |
|---|---|
| 200-Day MA | $2.76 |
| 1-Year Change | −73.56% |
| Market Cap | 14.56M |
|---|---|
| Shares Outstanding | 12.23M |
| Price to Book (P/B) | 0.49 |
| EV/EBITDA | 0.78 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Cellectar Biosciences at a Glance
As of the Oct 16, 2026 close, Cellectar Biosciences (CLRB) has a market capitalization of $14.56M.
As of its latest reported balance sheet, it holds $33.99M in cash and securities against $1.53M of debt, a net cash position of $32.46M.
Cellectar Biosciences does not currently pay a dividend.
The share price is down 73.6% over the past year. At $1.14 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.15 to $5.07, below its 200-day moving average of $2.76.
Frequently Asked Questions About Cellectar Biosciences
What is the current stock price for CLRB?
As of the Oct 16, 2026 close, CLRB stock trades at $1.14. The 52-week range is $1.15–$5.07, with a day range of $1.12–$1.28.
What is the P/E ratio for CLRB?
The P/E ratio (Price-to-Earnings) for CLRB is shown in the Key Statistics section. This valuation metric helps compare Cellectar Biosciences, Inc. to industry peers.
Does CLRB pay dividends?
Cellectar Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CLRB?
Analyst ratings and recommendations for CLRB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CLRB?
As of the Oct 16, 2026 close, Cellectar Biosciences's market capitalization is $13.9M, classifying it as a micro-cap company. Cellectar Biosciences operates in the Healthcare sector within the Biotechnology industry.